Susceptibility of clinical bacterial isolates to ciprofloxacin in the united states C. Thornsberry OriginalPaper Pages: S80 - S89
Prevalence of fluoroquinolone resistance in Europe M. KreskenD. Hafnerthe Study Group ‘Bacterial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy e. V. OriginalPaper Pages: S90 - S98
Prevalence of ciprofloxacin resistance in multiresistant gram-negative intensive care unit isolates Chandra M. KhuranaBette R. Wojack OriginalPaper Pages: S99 - S104
In vitro stepwise selection of resistance to quinolones, β-lactams and amikacin in nosocomial gram-negative bacilli M. Michéa-HamzehpourAnneliese KahrJ. -C. Pechère OriginalPaper Pages: S105 - S110
Quinolone resistance inPseudomonas aeruginosa andStaphylococcus aureus. Development during therapy and clinical significance A. Dalhoff OriginalPaper Pages: S111 - S121
Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients K. G. NaberF. WagenlehnerP. Heisig OriginalPaper Pages: S122 - S127
Analysis of nosocomial outbreaks with multiply and methicillin-resistantStaphylococcus aureus (MRSA) in Germany: Implications for hospital hygiene W. WitteChristine BraulkeChrista Cuny OriginalPaper Pages: S128 - S134
Control of an outbreak of methicillin-resistantStaphylococcus aureus (MRSA) by hygienic measures in a general intensive care unit W. LingnauF. Allerberger OriginalPaper Pages: S135 - S139
Bacterial resistance to fluoroquinolones: Lessons to be learned P. Ball OriginalPaper Pages: S140 - S147